News
Utrecht University researchers Bas van Ravensteijn and Markus Weingarth have each been awarded an ERC Proof of Concept Grant of €150.000 to further enhance antibiotics and nanomedice ...
Scientists in Tel Aviv and IIBR have developed an mRNA vaccine. It combats the deadly Yersinia pestis bacterium. This bacterium causes plague. The vaccine showed 100% effectiveness in animal trials.
Scientists from Tel Aviv University and the Israel Institute of Biological Research say their vaccine uses lipid ...
For decades, the dream of fixing harmful mutations in mitochondrial DNA felt out of reach. Scientists have long known these ...
Ticks and the diseases they carry are only becoming more common. But new treatments and vaccines might not be too far off.
Herein, we report mRNA-loaded polymeric nanoparticles based on diethylenetriamine-substituted poly (aspartic acid) that induce protein expression in the lungs and muscles following intravenous and ...
DNA makes RNA, RNA makes protein, protein makes phenotype—was the guiding framework for understanding inheritance and disease ...
In a paper published last month, researchers at UT Southwestern Medical Center introduced lipid nanoparticles — hollow, fatty ...
Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...
The global lipid nanoparticles (LNP) contract development and manufacturing organization (CDMO) market is poised for substantial double-digit growth by 2027, driven by the growing acceptance of LNPs ...
Electrostatic interaction plays a leading role in nanoparticle interactions with membrane architectures and can lead to effects such as nanoparticle binding and membrane disruption. In this work, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results